Ricerca avanzata per:
Risultati della ricerca
-
2. CV_CONCETTA_GIANCOLA (77%)
17-apr-2020 12.00.54-drug recognition in anticancer therapy”. Current Cancer Drug Targets (2007), 7(6), 520-540 ... , Barone G, Giancola C. “Quadruplex-forming oligonucleotides as tools in anticancer therapy and ... di Amministrazione dell’Università di Napoli Federico II. Giugno 2011 - oggi Membro dell’Organismo ... , inoltre, parte del Consiglio di Amministrazione dell’8niversitj Federico II da novembre 2 9 a luglio
-
3. giancola_cv (77%)
22-apr-2020 14.19.47in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo ... oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current ... in Scienze Chimiche (dal XXIV ciclo al XXIX ciclo). 10. Membro del Consiglio di Amministrazione
-
4. cv prof. giancola (77%)
14-apr-2022 16.51.45oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current Medicinal ... in Scienze Chimiche (dal XXIV ciclo al XXIX ciclo). 10. Membro del Consiglio di Amministrazione ... ), 16048-16056. 54. Pagano B, Giancola C*. “Energetics of quadruplex-drug recognition in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo A, Giancola C
-
5. biosketch_alcaro_jan_19 (64%)
10-apr-2020 10.33.26Grant FIRB on the project "New agents in the specific anticancer therapy". Role: PI
-
6. cv_santillo (64%)
31-mag-2023 11.02.37pathway of cholesterol and isoprenoids in human colorectal cancer: pathway inhibitors in anticancer therapy.” funded from Ministry of Health, 2000/2001 ADDITIONAL INFORMATION Projects
-
7. l1-cv-galizia (55%)
16-apr-2020 10.35.00Therapeutics Drugs European Journal of Surgical Oncology Expert Review of Anticancer Therapy Expert
-
8. stefano_alcaro_may_17 (55%)
7-nov-2017 14.22.33in the specific anticancer therapy". Role: PI of local unit 2009 Grant MIUR on the project "
-
9. cv prof. nicolai (47%)
6-apr-2022 11.17.34Head & Neck European Journal of Cancer Expert Review of Anticancer Therapy Head and